News

Biocon ties up with Belagavi-based manufacturer to make Remdesivir

Belagavi-based pharmaceutical company has been roped in to manufacture ‘Remidesvir’, which is given to critical Covid patients and is in short supply across the country

Read More

Jun 09, 2021

By : Team ABLE

Bharat Biotech, Ocugen expand COVAXIN commercialization rights to include Canada

Ocugen to have exclusive co-development, manufacturing, and commercialization rights to COVAXIN in Canada, in addition to its existing US rights

Read More

Jun 09, 2021

By : Team ABLE

Covaxin gets Brazilian regulator's conditional nod, Bharat Biotech to export 4 million doses

Anvisa, also known as the The National Health Surveillance Agency of Brazil, has approved the import of Bharat Biotech's Covaxin and Russia's Sputnik V vaccine into that country. Bharat Biotech a member of ABLE

Read More

Jun 09, 2021

By : Team ABLE

Serum Institute of India gets DCGI's nod to manufacture Sputnik V in India for test, analysis

The Pune-based firm, a Patron Gold member of ABLE, has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology in Moscow for developing Sputnik V at its licensed Hadapsar facility

Read More

Jun 09, 2021

By : Team ABLE

ABLE & Biocon Chief contributes Rs 5 cr for pandemic research to Ignite Life Science Foundation

Dr Kiran Mazumdar-Shaw contributes toward the initial pool of funding for the research projects on “Pandemic Preparedness”

Read More

Jun 07, 2021

By : Team ABLE

 

BioEconomy Conclave 2026

24th February | TAJ MG Road, Bengaluru

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Focus Areas

Highlights